Concepedia

Lidia Belousova

LB

Statistics

Publications

2

Citations

365

H-Index

2

Active since

2019

Affiliations

Novo Nordisk (Denmark)(Current)

Hebrew University of Jerusalem

Lidia Belousova is an author at Novo Nordisk (Denmark) specializing in clinical trials, nephrology, and diabetes.

ORCID

Top concepts

Publications per year

2019–2020

2

Publications

2

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 317 citations · Full text

, , +11

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial

Lawrence Blonde, Lidia Belousova, Udi Fainberg et al. · Diabetes Obesity and Metabolism · 2020 · 48 citations · Full text

1–2 of 2